Drug Shortage Report for ADENOSINE INJECTION
| Report ID | 156797 |
| Drug Identification Number | 02457482 |
| Brand name | ADENOSINE INJECTION |
| Common or Proper name | Adenosine Injection 3 mg/mL prefilled syringe 4 mL |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ADENOSINE |
| Strength(s) | 3MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 4mL |
| ATC code | C01EB |
| ATC description | OTHER CARDIAC PREPARATIONS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-03-16 |
| Actual start date | 2022-03-16 |
| Estimated end date | 2022-03-30 |
| Actual end date | 2022-04-01 |
| Shortage status | Resolved |
| Updated date | 2022-04-13 |
| Company comments | Short term backorder in certain areas. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-04-13 | French | Compare |
| v4 | 2022-04-13 | English | Compare |
| v3 | 2022-03-17 | English | Compare |
| v2 | 2022-03-16 | French | Compare |
| v1 | 2022-03-16 | English | Compare |
Showing 1 to 5 of 5